Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCAF8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ATP6V1G2-DDX39B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SPRED1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | AHI1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | GTPBP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TSPAN33 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | NDST2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CNPY1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | FAM46B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KLF8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |